Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(12 sites)
United States
Valkyrie Clinical Trials, Los Angeles, California Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center, Lake Mary, Florida Emory University Hospital, Atlanta, Georgia University of Minnesota, Minneapolis, Minnesota NYP/Weill Cornell Medical Center, New York, New York Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina University Hospitals Cleveland, Cleveland, Ohio Providence Cancer Institute Franz Clinic, Portland, Oregon Rhode Island Hospital, Providence, Rhode Island SCRI Oncology Partners, Nashville, Tennessee University of Texas MD Anderson Cancer Center, Houston, Texas NEXT Oncology Virginia, Fairfax, Virginia